Ms Cynthia Ann Pedersen, OTR/L, CHT | |
435 Phalen Blvd, Saint Paul, MN 55130-5302 | |
(651) 254-3200 | |
Not Available |
Full Name | Ms Cynthia Ann Pedersen |
---|---|
Gender | Female |
Speciality | Occupational Therapy |
Experience | 32 Years |
Location | 435 Phalen Blvd, Saint Paul, Minnesota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700922721 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 102401 (Minnesota) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Regions Hospital | 3173436755 | 159 |
News Archive
Today's headlines include weekend updates regarding the fiscal cliff negotiations as well as news regarding states' decisions on health exchanges.
Varian Medical Systems, the world's leading manufacturer of medical devices and software for treating cancer as well as a premier supplier of X-ray imaging components, today announced that it will expand its operations in Fulton County, Georgia. Company officials anticipate that this expansion will enable it to better serve its East Coast customers and accommodate anticipated growth that will create up to 100 new high-paying technical jobs over the next five years.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency (EMA) has accepted the filing of the Marketing Authorization Application (MAA) for ADCETRIS for the treatment of relapsed or refractory Hodgkin lymphoma (HL) and relapsed or refractory systemic anaplastic large cell lymphoma.
Partners HealthCare System Inc., which runs Boston's Massachusetts General Hospital, is borrowing $420 million for improvements including electronic medical records and to refinance debt, with average tax-exempt yields at close to a 16-month high.
Labopharm Inc. today announced that on November 11, 2010 it received notice from Actavis South Atlantic LLC advising that Actavis has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for approval to market 150 and 300 mg generic versions of OLEPTRO™ (trazodone hydrochloride extended-release 150 and 300 mg tablets) in the United States.
› Verified 3 days ago
Provider Name | Regions Hospital |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1154359917 PECOS PAC ID: 3173436755 Enrollment ID: O20031110000511 |
News Archive
Today's headlines include weekend updates regarding the fiscal cliff negotiations as well as news regarding states' decisions on health exchanges.
Varian Medical Systems, the world's leading manufacturer of medical devices and software for treating cancer as well as a premier supplier of X-ray imaging components, today announced that it will expand its operations in Fulton County, Georgia. Company officials anticipate that this expansion will enable it to better serve its East Coast customers and accommodate anticipated growth that will create up to 100 new high-paying technical jobs over the next five years.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency (EMA) has accepted the filing of the Marketing Authorization Application (MAA) for ADCETRIS for the treatment of relapsed or refractory Hodgkin lymphoma (HL) and relapsed or refractory systemic anaplastic large cell lymphoma.
Partners HealthCare System Inc., which runs Boston's Massachusetts General Hospital, is borrowing $420 million for improvements including electronic medical records and to refinance debt, with average tax-exempt yields at close to a 16-month high.
Labopharm Inc. today announced that on November 11, 2010 it received notice from Actavis South Atlantic LLC advising that Actavis has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for approval to market 150 and 300 mg generic versions of OLEPTRO™ (trazodone hydrochloride extended-release 150 and 300 mg tablets) in the United States.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Ms Cynthia Ann Pedersen, OTR/L, CHT 8170 33rd Ave S # Ms 21110q, Bloomington, MN 55425-4516 Ph: () - | Ms Cynthia Ann Pedersen, OTR/L, CHT 435 Phalen Blvd, Saint Paul, MN 55130-5302 Ph: (651) 254-3200 |
News Archive
Today's headlines include weekend updates regarding the fiscal cliff negotiations as well as news regarding states' decisions on health exchanges.
Varian Medical Systems, the world's leading manufacturer of medical devices and software for treating cancer as well as a premier supplier of X-ray imaging components, today announced that it will expand its operations in Fulton County, Georgia. Company officials anticipate that this expansion will enable it to better serve its East Coast customers and accommodate anticipated growth that will create up to 100 new high-paying technical jobs over the next five years.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency (EMA) has accepted the filing of the Marketing Authorization Application (MAA) for ADCETRIS for the treatment of relapsed or refractory Hodgkin lymphoma (HL) and relapsed or refractory systemic anaplastic large cell lymphoma.
Partners HealthCare System Inc., which runs Boston's Massachusetts General Hospital, is borrowing $420 million for improvements including electronic medical records and to refinance debt, with average tax-exempt yields at close to a 16-month high.
Labopharm Inc. today announced that on November 11, 2010 it received notice from Actavis South Atlantic LLC advising that Actavis has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for approval to market 150 and 300 mg generic versions of OLEPTRO™ (trazodone hydrochloride extended-release 150 and 300 mg tablets) in the United States.
› Verified 3 days ago
Ann E. Richter, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1600 University Ave W, Suite 10, Saint Paul, MN 55104 Phone: 651-999-1035 | |
Mrs. Lacey Maier, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 640 Jackson St, Saint Paul, MN 55101 Phone: 651-254-5540 | |
Kimberly R Pritchett, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 280 Smith Ave N Ste 500, Saint Paul, MN 55102 Phone: 651-968-5420 Fax: 651-222-0956 | |
Barbara Johnson, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 709 University Ave W, Saint Paul, MN 55104 Phone: 651-227-8471 | |
Lauren Eleise Dusek, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 333 Smith Ave N, Saint Paul, MN 55102 Phone: 651-241-8000 | |
Rebecca Jo Binder Marturano, OTR/L. Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1394 Jackson St, Saint Paul, MN 55117 Phone: 651-603-8774 | |
Cynthia L Wagner, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 310 Smith Ave N Ste 370, Saint Paul, MN 55102 Phone: 651-223-5406 Fax: 651-287-3777 |